Old Web
English
Sign In
Acemap
>
Paper
>
POS-686 UِSE OF BORTEZOMIB IN TREATMENT OF KIDNEY TRANSPLANT SUB-CLINICAL ANTIBODY MEDIATED REJECTION
POS-686 UِSE OF BORTEZOMIB IN TREATMENT OF KIDNEY TRANSPLANT SUB-CLINICAL ANTIBODY MEDIATED REJECTION
2021
A. Al-Omairi
E. Dijke
A. Alabbas
Keywords:
kidney transplant
sub clinical
antibody mediated rejection
Bortezomib
Internal medicine
Oncology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]